PMX-622 (Polymyxin B-Dextran 70) Does Not Alter In Vitro Activities of 11 Antimicrobial Agents

Because of its capacity to neutralize the lethality of gram-negative bacterial endotoxic lipopolysaccharides, PMX-622 (polymyxin B bound to dextran 70) is being developed for possible adjunctive therapy of gram-negative sepsis. In this study, it was determined that the in vitro antimicrobial activit...

Description complète

Détails bibliographiques

Publié dans:	Antimicrob Agents Chemother
Auteurs principaux:	Fuchs, Peter C., Barry, Arthur L., Brown, Steven D.
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Microbiology (ASM) 1998
Sujets:	Susceptibility
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105937/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9756795/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.10.2765
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!